SEC Form 4 · accession 0001683168-17-002952
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hideki Nagao
Director
Period of report
Nov 9, 2017
Accepted (ET)
Nov 13, 2017 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.51 | Nov 9, 2017 | A | 20,000 | A | Nov 9, 2017 | Nov 8, 2027 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy)F1 | $6.51 | Nov 9, 2017 | A | 15,000 | A | — | Nov 8, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests in three equal installments on December 31, 2017, March 31, 2018 and June 30, 2018, subject to continued service with the Company.